The UK biotech sector has fallen victim to the mayhem in the capital markets. After a year of falling share prices, five quoted companies have put up “for sale” signs.

Corporate incubators bridge the seed funding gap, but apart from pocket money what can start-ups learn from their foster parents?

The European Commission has selected six areas of pioneering research for its long-awaited lead markets initiative.

Private equity firm Celtic Pharma is launching two new funds worth $1.5 billion in total, to invest in development-stage biotech companies and products.

Consumer products giant Procter and Gamble is applying its knowledge of consumers to the development of new medicines – and wants to share its insights with biotech companies.